tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2021 Dec 30;10(1):43.
doi: 10.3390/vaccines10010043.
Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination
Tina Y Poussaint[SUP] 1 [/SUP], Kerri L LaRovere[SUP] 2 [/SUP], Jane W Newburger[SUP] 3 4 [/SUP], Janet Chou[SUP] 4 5 [/SUP], Lise E Nigrovic[SUP] 4 6 [/SUP], Tanya Novak[SUP] 7 [/SUP], Adrienne G Randolph[SUP] 4 7 [/SUP]
Affiliations
Abstract
A 12-year-old male was presented to the hospital with acute encephalopathy, headache, vomiting, diarrhea, and elevated troponin after recent COVID-19 vaccination. Two days prior to admission and before symptom onset, he received the second dose of the Pfizer-BioNTech COVID-19 vaccine. Symptoms developed within 24 h with worsening neurologic symptoms, necessitating admission to the pediatric intensive care unit. Brain magnetic resonance imaging within 16 h of admission revealed a cytotoxic splenial lesion of the corpus callosum (CLOCC). Nineteen days prior to admission, he developed erythema migrans, and completed an amoxicillin treatment course for clinical Lyme disease. However, Lyme antibody titers were negative on admission and nine days later, making active Lyme disease an unlikely explanation for his presentation to hospital. An extensive workup for other etiologies on cerebrospinal fluid and blood samples was negative, including infectious and autoimmune causes and known immune deficiencies. Three weeks after hospital discharge, all of his symptoms had dissipated, and he had a normal neurologic exam. Our report highlights a potential role of mRNA vaccine-induced immunity leading to MIS-C-like symptoms with cardiac involvement and a CLOCC in a recently vaccinated child and the complexity of establishing a causal association with vaccination. The child recovered without receipt of immune modulatory treatment.
Keywords: COVID-19 mRNA vaccine; cytotoxic lesion of the corpus callosum; multisystem inflammatory syndrome in children; severe acute respiratory syndrome coronavirus 2.
. 2021 Dec 30;10(1):43.
doi: 10.3390/vaccines10010043.
Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination
Tina Y Poussaint[SUP] 1 [/SUP], Kerri L LaRovere[SUP] 2 [/SUP], Jane W Newburger[SUP] 3 4 [/SUP], Janet Chou[SUP] 4 5 [/SUP], Lise E Nigrovic[SUP] 4 6 [/SUP], Tanya Novak[SUP] 7 [/SUP], Adrienne G Randolph[SUP] 4 7 [/SUP]
Affiliations
- PMID: 35062704
- DOI: 10.3390/vaccines10010043
Abstract
A 12-year-old male was presented to the hospital with acute encephalopathy, headache, vomiting, diarrhea, and elevated troponin after recent COVID-19 vaccination. Two days prior to admission and before symptom onset, he received the second dose of the Pfizer-BioNTech COVID-19 vaccine. Symptoms developed within 24 h with worsening neurologic symptoms, necessitating admission to the pediatric intensive care unit. Brain magnetic resonance imaging within 16 h of admission revealed a cytotoxic splenial lesion of the corpus callosum (CLOCC). Nineteen days prior to admission, he developed erythema migrans, and completed an amoxicillin treatment course for clinical Lyme disease. However, Lyme antibody titers were negative on admission and nine days later, making active Lyme disease an unlikely explanation for his presentation to hospital. An extensive workup for other etiologies on cerebrospinal fluid and blood samples was negative, including infectious and autoimmune causes and known immune deficiencies. Three weeks after hospital discharge, all of his symptoms had dissipated, and he had a normal neurologic exam. Our report highlights a potential role of mRNA vaccine-induced immunity leading to MIS-C-like symptoms with cardiac involvement and a CLOCC in a recently vaccinated child and the complexity of establishing a causal association with vaccination. The child recovered without receipt of immune modulatory treatment.
Keywords: COVID-19 mRNA vaccine; cytotoxic lesion of the corpus callosum; multisystem inflammatory syndrome in children; severe acute respiratory syndrome coronavirus 2.